This GSDME-dependent pyroptosis could convert chemotherapy-induced cell death from non-immunogenic apoptosis to immunogenic pyroptosis and augment anti-tumor immune responses in preclinical models31,52. This evidence concerns the gene GSDME and neoplasm.